EMA GMP Inspection INS/GMP/2018/111; INS/GMP/2018/112; INS/GMP/2019/063 and INS/GMP/2019/064 - Zhejiang Hisun Pharmaceutical Co., Ltd. - April 19, 2022
EMA GMP Inspection INS/GMP/2018/111; INS/GMP/2018/112; INS/GMP/2019/063 and INS/GMP/2019/064 for Zhejiang Hisun Pharmaceutical Co., Ltd. on April 19, 2022. Site: Zhejiang Hisun Pharmaceutical Co. Ltd.. Access full inspection details and observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
EMA GMP Inspection INS/GMP/2018/111; INS/GMP/2018/112; INS/GMP/2019/063 and INS/GMP/2019/064 for Zhejiang Hisun Pharmaceutical Co., Ltd. on April 19, 2022. Site: Zhejiang Hisun Pharmaceutical Co. Ltd.. Access full inspection details and observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
March 26, 2019
Product Type
drugs
ID: af958589-e931-44bd-9f0d-7851c5e1d6d3
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox